VK2809
id:
vk2809-189-14727531
title:
VK2809
text:
VK2809 is a thyromimetic prodrug whose active form is selective for the THR-β isoform. It is being developed by Viking Therapeutics in a phase II trial for the treatment of nonalcoholic steatohepatitis and is also being investigated for glycogen storage disease type Ia.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/VK2809
date created:
2023-09-15T20:37:08Z
date modified:
2024-09-09T09:03:14Z
main entity:
{"identifier":"Q27258223","url":"https://www.wikidata.org/entity/Q27258223"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/b/bf/VK2809.svg","width":1005,"height":380}
fields total:
13
integrity:
16